<DOC>
	<DOCNO>NCT01268592</DOCNO>
	<brief_summary>The purpose study preserve fertility potential female diagnose cancer vitrifying ( rapidly freeze ) oocyte ( egg ) undergo treatment cancer .</brief_summary>
	<brief_title>Fertility Preservation Female Cancer Patients</brief_title>
	<detailed_description />
	<criteria>Patients must 1442 year old female cancer diagnosis . Clearance letter treat oncologist . Approval program oncologist designee . Informed consent sign consultation program physician . Minors require consent parent legal guardian assent participant . Life expectancy ( predicted malignancy ) 5 year . Cancer diagnosis expect cure rate 50 % , base upon clinicopathologic feature . Patients whose oncologist program oncologist concur immediate oncologic care render , allow sufficient time course gonadotropin therapy egg retrieval . FSH level &gt; 20 MIU/ml , indicate abnormal ovarian function . Patients stage IV cancer ( *age appropriate woman stage IV advance Hodgkin 's Lymphoma consider , significant long term survival rate advance disease ) . Patients incurable cancer diagnosis . Patients unable unwilling sign inform consent . Women embryo transfer beyond age 50 .</criteria>
	<gender>Female</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>fertility preservation</keyword>
	<keyword>oocyte cryopreservation</keyword>
	<keyword>vitrification</keyword>
	<keyword>egg freeze</keyword>
	<keyword>fertility preservation female cancer patient</keyword>
</DOC>